# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-119726
Filing Date
2025-12-09
Accepted
2025-12-09 17:26:01
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | tm2533062d1_424b3.htm | 424B3 | 1849830
2 | GRAPHIC | tm2533062d1_424b3img08.jpg | GRAPHIC | 4277
3 | GRAPHIC | tm2533062d1_424b3img07.jpg | GRAPHIC | 198851
4 | GRAPHIC | tm2533062d1_424b3img06.jpg | GRAPHIC | 78625
5 | GRAPHIC | tm2533062d1_424b3img05.jpg | GRAPHIC | 106553
6 | GRAPHIC | tm2533062d1_424b3img04.jpg | GRAPHIC | 87016
7 | GRAPHIC | tm2533062d1_424b3img03.jpg | GRAPHIC | 53099
8 | GRAPHIC | tm2533062d1_424b3img02.jpg | GRAPHIC | 162490
9 | GRAPHIC | tm2533062d1_424b3img09.jpg | GRAPHIC | 17624
10 | GRAPHIC | tm2533062d1_424b3img01.jpg | GRAPHIC | 7043
| Complete submission text file | 0001104659-25-119726.txt |  | 2811362

Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-290954 | Film No.: 251560054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)